Clinical Study
Performance of Clinical Criteria for Screening of Possible Antiretroviral Related Mitochondrial Toxicity in HIV-Infected Children in Accra
Table 3
MDC and EPF total scores.
| | | HAART Experienced
()
(%) | HAART Naive
()
(%) | value |
| | MDC categories | | | | Metabolic disease unlikely
(0-1 point) | 220 (66.5) | 52 (69.4) | | Metabolic disease possible
(2–4 points) | 110 (33.3) | 22 (29.23) | 0.81 | Metabolic disease probable
(5–7 points) | 1 (0.3) | 1 (1.4) | | | EPF categories | | | | | Positive | 53 (16.0) | 6 (8.3) | | | Negative | 278 (83.9) | 66 (91.6) |
0.10 |
|
|
